
Priced past autonomy certainty: initiate at Sell, $333.38 target (−14.6%), Low conviction
We initiate at Sell with a $333.38 target (−14.6% return) and Low conviction, as plausible discount-rate or software inputs flip the call. Tesla sells EVs, grid storage, charging and FSD software while funding pre-revenue robotaxi and humanoid programmes. At $390.22, the share price implies 1.20x unrisked robotaxi success ahead of a multi-year cash trough.
- Venture spend puts FY27E non-GAAP EPS 28.1% below Street ($1.55 vs $2.16) and turns FCF deeply negative. 3Q26 R&D jumped 69% y/y to $2.76bn; capex reaches $25.2bn in FY27E and $30.0bn in FY28E, holding GAAP EBIT margin below 1% and FCF at −$10.6bn and −$12.8bn.
- $390.22 demands $303.98/sh from robotaxi—7.93m cars by FY35E at certainty—leaving skewed downside. Weighting four analyst-set outcomes (10% fail, 20% niche, 50% success at 6.6m cars, 20% dominant) values robotaxi at $230.18/sh, $73.80/sh below price-implied value.
- In our SOTP, core cars ($12.76), energy ($7.31) and FSD ($31.65) total $51.71/sh, or $38.86/sh net of $12.85/sh programme spend. Ex $187m net energy tariff refunds ($526m COGS credit less $339m customer pass-through), 3Q26 energy GM is ~24% vs 33.1% reported, and cell supply caps FY30E deliveries at 2.43m vs ~5m ambition.
What the market is missing. Consensus models FY27E non-GAAP EPS rising 24% to $2.16, whereas our model deducts $7.65bn of venture R&D (incl. $2.65bn programme D&A), holding EPS at $1.55 and cutting net cash from $35.9bn (3Q26) to $8.7bn by FY28E.
Catalysts. Dallas Cybercab rides (Nov 2026), 4Q26 results & FY27 capex guide (late Jan 2027), EU FSD ruling (1Q27) and targeted unsupervised customer FSD in 2Q27 (+$25.29/sh unrisked).
Valuation and target. SOTP DCF (11.57% WACC, 11.62% Ke, 3.0% g) gives $316.42/sh base value (peer P/E check $269.02/sh). Weighting Bear ($175.48, 30%), Base ($316.42, 50%) and Bull ($439.16, 20%) yields $298.69/sh today and rolls at Ke to $333.38 (−14.6%; 0.51x Bull/Bear skew).
Risks. On-time 2Q27 customer autonomy (+$25.29/sh) or −100bp WACC ($399.32 target, Hold) are key upside risks to Sell; Congressional AV oversight (−$25.29/sh) and export pricing (−$6.56/sh) lead downside.
| Dec YE, US$m | FY24A | FY25A | FY26E | FY27E | FY28E |
|---|---|---|---|---|---|
| Revenue | 97,690 | 94,827 | 107,389 | 120,660 | 133,788 |
| Growth y/y | +0.9% | −2.9% | +13.2% | +12.4% | +10.9% |
| Adjusted EBITDA | 16,056 | 14,596 | 13,773 | 14,328 | 17,357 |
| Margin | 16.4% | 15.4% | 12.8% | 11.9% | 13.0% |
| Net income (GAAP) | 7,091 | 3,794 | 2,639 | 1,547 | 1,606 |
| EPS, GAAP ($) | 2.04 | 1.08 | 0.74 | 0.44 | 0.45 |
| Growth y/y | −52.6% | −47.1% | −31.1% | −41.3% | +3.8% |
| Free cash flow | 3,581 | 6,220 | −1,947 | −10,582 | −12,848 |
| At $390.22 (13 Nov) | FY24A | FY25A | FY26E | FY27E | FY28E |
|---|---|---|---|---|---|
| P/E (GAAP) | 191.3x | 361.3x | 524.8x | 893.7x | 860.9x |
| EV / Adj. EBITDA | 93.8x | 103.2x | 109.4x | 105.1x | 86.8x |
| P / B | 18.7x | 16.8x | 15.2x | 14.3x | 13.3x |
| FCF yield | 0.3% | 0.5% | −0.1% | −0.8% | −0.9% |
| Dividend yield | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% |
| ROE (GAAP) | 10.5% | 4.9% | 3.1% | 1.6% | 1.6% |
| Net debt / EBITDA | −1.8x | −2.4x | −2.3x | −1.5x | −0.5x |
| Target P/E (GAAP) | 163.4x | 308.7x | 448.3x | 763.6x | 735.5x |
Source: Company filings, Yahoo Finance, Penmark Research model. Non-GAAP EPS: $1.56 FY26E, $1.55 FY27E, $1.66 FY28E (249.6x/251.4x/235.5x at price; 213.3x/214.7x/201.2x at target).
Base SOTP is $316.42/share; our scenario-weighted $333.38 target (−14.6%) has 0.51x Bull/Bear target skew
Source: Yahoo Finance; Penmark Research model
Value today $439.16. Deliveries +16% FY27E; hardware GM 18.5–19.5%; energy GM 29%; FSD 21m by FY40E; robotaxi dominant 35%, Optimus 25%.
Value today $316.42. Deliveries +10% FY27E; hardware GM 16.5–17.5%; energy GM 26%; FSD 10m by FY34E; robotaxi success 50% (6.6m FY35E), Optimus 35%.
Value today $175.48. Deliveries +2%/yr; hardware GM 14%; energy GM 21%; FSD 7.5m by FY40E; robotaxi fail 25%, Optimus fail 45% on AV oversight.
| Income stmt, US$m | FY24A | FY25A | FY26E | FY27E | FY28E |
|---|---|---|---|---|---|
| Revenue | 97,690 | 94,827 | 107,389 | 120,660 | 133,788 |
| Gross profit | 17,450 | 17,094 | 20,137 | 22,548 | 26,413 |
| Adjusted EBITDA | 16,056 | 14,596 | 13,773 | 14,328 | 17,357 |
| GAAP EBIT | 7,076 | 4,355 | 2,052 | 774 | 1,252 |
| Net interest & other | 1,852 | 962 | 1,315 | 1,210 | 808 |
| Income tax | −1,837 | −1,423 | −684 | −436 | −453 |
| Non-GAAP net inc. | n/d | n/d | 5,519 | 5,502 | 5,872 |
| GAAP net income | 7,091 | 3,794 | 2,639 | 1,547 | 1,606 |
| Cash flow, US$m | FY24A | FY25A | FY26E | FY27E | FY28E |
|---|---|---|---|---|---|
| GAAP net income | 7,091 | 3,794 | 2,639 | 1,547 | 1,606 |
| D&A | 5,368 | 6,148 | 6,860 | 8,840 | 10,996 |
| SBC & working cap. | 2,464 | 4,805 | 8,568 | 4,184 | 4,584 |
| Operating cash flow | 14,923 | 14,747 | 18,067 | 14,571 | 17,186 |
| Core capex | −11,342 | −8,527 | −8,312 | −9,653 | −10,034 |
| Venture capex | 0 | 0 | −11,702 | −15,500 | −20,000 |
| Free cash flow | 3,581 | 6,220 | −1,947 | −10,582 | −12,848 |
| Credit facility draw | 0 | 0 | 0 | 0 | 6,813 |
| Balance sheet, US$m | FY24A | FY25A | FY26E | FY27E | FY28E |
|---|---|---|---|---|---|
| Cash & investments | 36,563 | 44,059 | 41,617 | 31,035 | 25,000 |
| SpaceX stake | 0 | 0 | 2,900 | 2,900 | 2,900 |
| Depreciable assets | n/d | n/d | 64,292 | 80,605 | 99,642 |
| of which programme | 0 | 0 | 15,276 | 28,128 | 43,743 |
| Net assets / capital | 81,126 | 90,513 | 100,209 | 106,472 | 119,999 |
| Debt & leases | 8,213 | 8,376 | 9,523 | 9,523 | 16,336 |
| Net cash / (debt) | 28,350 | 35,683 | 32,094 | 21,512 | 8,664 |
| Common equity | 72,913 | 82,137 | 90,686 | 96,949 | 103,664 |
| Per share & KPIs | FY24A | FY25A | FY26E | FY27E | FY28E |
|---|---|---|---|---|---|
| Diluted shares (m) | 3,498 | 3,528 | 3,544 | 3,544 | 3,544 |
| EPS, non-GAAP ($) | n/d | n/d | 1.56 | 1.55 | 1.66 |
| EPS, GAAP ($) | 2.04 | 1.08 | 0.74 | 0.44 | 0.45 |
| FCF per share ($) | 1.02 | 1.76 | −0.55 | −2.99 | −3.63 |
| Book value / sh ($) | 20.84 | 23.28 | 25.59 | 27.36 | 29.25 |
| Deliveries (k) | 1,789 | 1,636 | 1,805 | 1,985 | 2,144 |
| Storage (GWh) | 31.4 | 46.7 | 52.0 | 67.6 | 82.5 |
| FSD paid subs (m) | n/d | 1.10 | 1.95 | 2.80 | 3.70 |
Source: Company filings, Signals KPIs, Penmark Research model. Diluted shares exclude 423.7m unearned 2025 CEO award shares until tranches vest; n/d = annual non-GAAP / combined depreciable line not disclosed in 10-K (9M26A non-GAAP NI $4,303m, EPS $1.22).
GAAP EBIT margin troughs at 0.6% in FY27E as $25.2bn capex and R&D leave our non-GAAP EPS 28.1% below consensus
| Growth, margins (%) | FY24A | FY25A | FY26E | FY27E | FY28E |
|---|---|---|---|---|---|
| Growth y/y | |||||
| Sales | +0.9% | −2.9% | +13.2% | +12.4% | +10.9% |
| Adjusted EBITDA | −3.5% | −9.1% | −5.6% | +4.0% | +21.1% |
| GAAP EBIT | −20.4% | −38.5% | −52.9% | −62.3% | +61.7% |
| GAAP EPS | −52.6% | −47.1% | −31.1% | −41.3% | +3.8% |
| Non-GAAP EPS | n/d | n/d | n/d | −0.7% | +6.7% |
| Margins & intensity | |||||
| Gross margin | 17.9% | 18.0% | 18.8% | 18.7% | 19.7% |
| Adj. EBITDA margin | 16.4% | 15.4% | 12.8% | 11.9% | 13.0% |
| GAAP EBIT margin | 7.2% | 4.6% | 1.9% | 0.6% | 0.9% |
| FCF margin | 3.7% | 6.6% | −1.8% | −8.8% | −9.6% |
| R&D / sales | 4.6% | 6.8% | 9.5% | 10.8% | 11.9% |
| Capex / sales | 11.6% | 9.0% | 18.6% | 20.8% | 22.4% |
| Ratios and valuation | FY24A | FY25A | FY26E | FY27E | FY28E |
|---|---|---|---|---|---|
| Returns and leverage | |||||
| ROE (GAAP) | 10.5% | 4.9% | 3.1% | 1.6% | 1.6% |
| ROA (GAAP) | 6.2% | 2.9% | 1.8% | 1.0% | 0.9% |
| ROCE (NOPAT/cap.) | 12.6% | 7.5% | 3.0% | 0.9% | 1.1% |
| Net debt / equity | −38.9% | −43.4% | −35.4% | −22.2% | −8.4% |
| Net debt / EBITDA | −1.8x | −2.4x | −2.3x | −1.5x | −0.5x |
| Valuation at $390.22 | |||||
| P/E (non-GAAP) | n/d | n/d | 249.6x | 251.4x | 235.5x |
| P/E (GAAP) | 191.3x | 361.3x | 524.8x | 893.7x | 860.9x |
| EV / Adj. EBITDA | 93.8x | 103.2x | 109.4x | 105.1x | 86.8x |
| P / B | 18.7x | 16.8x | 15.2x | 14.3x | 13.3x |
| FCF yield | 0.3% | 0.5% | −0.1% | −0.8% | −0.9% |
| Target P/E (non-GAAP) | n/d | n/d | 213.3x | 214.7x | 201.2x |
Source: Company filings, Signals ratios, Penmark Research model. Multiples at $390.22 (13 Nov 2026), except final row at our $333.38 12-month target.
| US$m / US$ per sh | 9M26A | 4Q26E | FY26E | FY27E |
|---|---|---|---|---|
| Revenue (US$m) | ||||
| Penmark (9M act.) | 78,669 | 28,720 | 107,389 | 120,660 |
| Consensus | n/a | 29,081 | 107,750 | 122,300 |
| Prior-year period | 69,926 | 24,901 | 94,827 | 107,389 |
| Diff. vs consensus | n/a | −1.2% | −0.3% | −1.3% |
| Growth y/y (Penmark) | +12.5% | +15.3% | +13.2% | +12.4% |
| Non-GAAP EPS ($) | ||||
| Penmark (9M act.) | 1.22 | 0.34 | 1.56 | 1.55 |
| Consensus | n/a | 0.52 | 1.74 | 2.16 |
| Prior-year period | n/d | 0.50 | n/d | 1.56 |
| Diff. vs consensus | n/a | −33.9% | −10.2% | −28.1% |
| Growth y/y (Penmark) | n/d | −31.4% | n/d | −0.7% |
Source: Filings, Yahoo Finance 14 Nov snapshot (4Q26E rev & EPS implied as FY26E less 9M26A; standalone 4Q26E EPS $0.50 in live YF, $0.49 prior; live 1Q27E $26,502m/$0.46), Q3 Update, Penmark model.
Source: Company filings (A); Yahoo Finance consensus; Penmark Research estimates (E)
At 249.6x FY26E P/E versus the 6.1x automaker median, TSLA leaves no cushion if autonomy slips
| At $390.22 (13 Nov) | TSLA | Auto med. | Diff. |
|---|---|---|---|
| Valuation | |||
| Forward P/E (CY26E)* | 249.6x | 6.1x | +3,973% |
| Trailing P/E (13 Nov)* | 428.8x | 23.0x | +1,761% |
| EV / EBITDA (TTM) | 153.9x | 12.4x | +1,139% |
| Dividend yield | 0.0% | n/a | No payout |
| Growth, margins and scale | |||
| Revenue growth (TTM) | 12.5% | 5.9% | +6.6pp |
| Operating margin (TTM) | 3.3% | 2.3% | +1.0pp |
| EBITDA margin (TTM) | 9.5% | 10.1% | −0.6pp |
| ROE (FY25A GAAP) | 4.9% | n/d | Depressed |
| Net debt / EBITDA | −2.4x | n/d | −$35.9bn cash |
| Active FSD subs (3Q26) | 1.74m | 0.00m | +1.74m |
Source: Penmark Research model (GM 6.1x, Ford 6.3x, Stellantis 5.1x CY26E P/E; Toyota 9.1x, Ferrari 37.0x trailing), Signals, Yahoo Finance. *TSLA 249.6x on Penmark FY26E EPS (180.7x YF NTM); 428.8x at $390.22 vs 390.6x 3Q26 end.
- Nov 26Dallas Cybercab rides: commercial autonomous dispatch test beyond Austin.
- Jan 274Q26 results & FY27 capex: tests ex-refund energy margin (25% est.) & $25.2bn capex.
- 1Q 27EU FSD decision: wider UNECE/national clearance (+$0.73/sh unrisked; 50% prob.).
- 2Q 27Customer unsupervised FSD: management target window (+$25.29/sh unrisked; 40% prob.).
Source: Q3 2026 Update & call, Penmark Research model.
- Unsupervised customer FSD on schedule (upside risk to Sell). Paid driverless customer cars in 2Q27 lift success odds. Med (40%); +$25.29/sh.
- Congressional AV oversight. Federal approval framework slows driverless rollout. Med (30%); −$25.29/sh.
- Chinese EV export pricing. Aggressive export ASPs cut Tesla hardware ASP by 3%. Med (40%); −$6.56/sh.
- Post-refund energy margin reset. 3Q26’s 33.1% margin normalises as tariff refunds end. Med (35%); −$1.67/sh.
Source: Signals quarter-end key metrics (4Q21-3Q26); Yahoo Finance
Source: Yahoo Finance; Signals peer statistics as of 13 Nov 2026
FSD attach drives sentiment, but 1.98x opex puts FY27E EPS 28% below Street while $390 embeds 7.9m robotaxis
Source: Signals KPI series (2Q25-3Q26); Yahoo Finance
Source: Company filings (A); Penmark Research estimates (E)
Source: Yahoo Finance consensus (35/33 analysts); Penmark Research estimates
Source: Penmark Research model
Source: Signals quarter-end key metrics (4Q21-3Q26); Yahoo Finance
Source: Penmark Research model; Yahoo Finance as of 13 Nov 2026
We sit above Morgan Stanley on robotaxi (+$118/sh) but $163/sh lower across FSD, cars and energy
| Debate | Market / Street | Penmark view | Key evidence | Changes view | Resolves |
|---|---|---|---|---|---|
| 1. Robotaxi scale & economics | Price embeds $303.98/sh (7.93m cars); MS $112/sh today. | $230.18/sh across 4 analyst-set outcomes (6.6m FY35E success). | Waymo runs ~4k AVs & 500k rides/wk; Tesla has hundreds & $0.30/mi unreached. | >5k paid driverless customer cars in 2027. | 2Q 2027 |
| 2. FSD ARPU & fleet attach | MS puts FSD/network at $130/sh today ($145 12m target). | $31.65/sh ($110.7bn EV): 10m subs FY34E at $3,323/yr FY36E ARPU. | Subs hit 1.74m in 3Q26 (75% NA attach), but EU/China lag & R&D is $3.5bn/yr. | EU unsupervised approval & >3.5m subs end-27. | 1Q–2Q 27 |
| 3. Optimus external sales | MS credits $35/sh today ($39 12m) on factory rollout. | $36.54/sh across 4 outcomes (20% fail; 8m/yr FY40E success). | Fremont S/X lines converting; external sales start late 2027, 1m/yr >1yr later. | >50k binding external orders at >25% GM. | End 2027 |
| 4. Core cars & energy margin | Street $2.16 FY27E EPS; MS puts core & energy at $85/sh. | $20.07/sh gross, or $7.22/sh net of −$12.85/sh programme spend. | 3Q26 EBIT ($718m) held $447m net tariff refunds ($187m net energy: ~24% GM vs 33.1%). | Auto ex-credit GM >19% & energy >29% clean. | Late Jan 27 |
Source: Company filings & Q3 call, Waymo, Penmark Research model; Morgan Stanley public SOTP discounted 12m at 11.62% Ke (not like-for-like: MS network services incl. insurance, charging & licensing carried in our cars/services).
Source: Penmark Research model; Morgan Stanley public SOTP (*not like-for-like: incl. insurance/charging)
How the debates map to the thesis
Three thesis chapters test every dollar of our gap to the share price. Debate 4 anchors Chapter 10 (Venture spend & cash trough, p. 16 & 20–21), showing why FY27E EPS sits 28.1% below consensus. Debate 1 anchors Chapter 11 (Robotaxi risk-reward, p. 17). Debates 2–3 anchor Chapter 12 (FSD & core hardware/energy, p. 18).
Where consensus and price diverge from our build
Extrapolating 3Q26 margins while pricing unrisked autonomy omits the investment bridge. 3Q26 included $447m net tariff refunds, while scaling autonomy and robotics requires an estimated $62.2bn of FY26E–30E venture capex in our model.
Source: Q3 2026 call; company calendar; Penmark Research
A $94.8bn car and battery maker priced at $1.54tn for a robotaxi fleet still measured in hundreds
Tesla builds electric vehicles, grid-scale battery packs and fast-charging stations that brought in $94.8bn of revenue in FY25, yet 87% of its $390.22 share price (78% from robotaxi alone) rests on driverless fleets and humanoid robots that earn almost nothing today. Between its factories and that autonomous future lies an estimated $75.2bn three-year capital-spending bill that turns free cash flow negative.
The scene
On an autumn afternoon in Austin, a Tesla operating without a human at the wheel threads city traffic while engineers watch telemetry from a control room. Miles away at Gigafactory Texas, stamping presses turn out Model Y crossovers and Cybertrucks for retail buyers alongside utility-scale Megapacks bound for AI data centres. Those two scenes capture Tesla in November 2026: an industrial manufacturer using car and battery cash flows to fund a high-wire bet on physical artificial intelligence.
What it actually does
Today Tesla sells four things. Passenger electric cars—led by Model 3 and Model Y—are sold online and through 1,553 store and service sites (end-FY25) without franchised dealers. Stationary battery systems—Powerwall for homes and Megapack for grids—reached 46.7 GWh in FY25 and 36.0 GWh in 9M26. Ecosystem services span Supercharging, parts, repair and insurance. And Full Self-Driving (Supervised) software counted 1.74m active subscribers by 3Q26.
Why it works, and why it might not
Direct retail, seamless fast charging and 75% North American FSD attach in 3Q26 keep drivers loyal. What could break the loop (Debates 1 & 4) is timing: if driverless customer cars slip past 2Q27 while $62.2bn of FY26E–30E venture capex drains net cash from $35.9bn to $8.7bn, shareholders are paying upfront for certainty they do not yet own.
How the money comes in
Buyers pay upfront on delivery for cars and Megapacks, per kilowatt-hour at Superchargers, and monthly or upfront for FSD software. In FY25, automotive generated $69.5bn (73.3% of sales, incl. $2.0bn of zero-cost regulatory credits), energy storage $12.8bn (13.5%) and services $12.5bn (13.2%). Out of each revenue dollar, 82.0 cents built and serviced the product, leaving 18.0 cents of gross profit; R&D (6.8 cents) and SG&A plus restructuring (6.7 cents) left 4.6 cents ($4.36bn) of GAAP operating profit and 6.6 cents ($6.22bn) of free cash flow.
Where the story turns
From 2022 to 2026, price cuts, Chinese EV competition and the July 2025 repeal of US consumer EV tax credits compressed GAAP operating margin from 16.8% in FY22 to 2.6% in 9M26. Rather than harvest cash, Tesla doubled down: 3Q26 R&D jumped 69% y/y to $2.76bn, Fremont Model S/X bays began converting to Optimus robot assembly, and FY26 capex was set near $20bn ahead of a Terafab and AI-compute wave peaking at $30.0bn in FY28E.
Source: FY2025 10-K, Signals KPIs, Penmark Research model (FY27E hardware & allocated core opex).
Hardware and services generated all $94.8bn of FY25A revenue, leaving $4.4bn (4.6%) of GAAP operating profit
Source: FY2025 Form 10-K; Penmark Research model (opex allocated by revenue)
What it sells, to whom, and why customers buy
Tesla monetises a shared battery, power-electronics and AI software stack across retail drivers, utilities and fleet owners. Retail and commercial EV buyers purchase Model 3/Y, Cybertruck and Model S/X ($69.5bn in FY25A; $57.3bn in 9M26A) for total cost of ownership, integrated NACS Supercharging (84,465 connectors in 3Q26) and over-the-air FSD updates. Utilities, IPPs and data-centre operators buy turnkey Megapack systems ($12.8bn in FY25A; $8.4bn in 9M26A) to buffer renewable intermittency and AI-load spikes. Services & other ($12.5bn in FY25A; $12.9bn in 9M26A) monetises the >7m-vehicle installed base via paid charging, parts, collision repair and insurance.
Pricing, payment model and the revenue equation
Consolidated revenue follows a hybrid unit-times-price plus recurring-software equation. Hardware revenue equals deliveries × ASP ex credits/FSD plus zero-cost regulatory credits ($1,993m FY25A, $639m 9M26A); energy equals GWh deployed × price/GWh ($273m/GWh FY25A, $234m/GWh 9M26A); FSD (carved out from FY27E; ~$800m est. in FY26E) equals average paid subscribers × annual ARPU. Vehicles and Megapacks settle in cash or third-party financing on delivery, whereas FSD bills monthly ($99/mo in North America) alongside upfront purchases.
Cash versus profit: working capital, deferred revenue & capex
Negative net operating working capital cushions cash flow, but venture capex overwhelms operating cash generation in FY26E–28E. At 30 Sep 2026, accounts payable ($17.2bn) and deferred revenue ($4.66bn, incl. unrecognised FSD and service obligations) exceeded receivables ($4.64bn) and inventory ($14.09bn), leaving −$8.63bn of other net operating assets. Even so, capex jumping from $8.53bn in FY25A to $20.01bn–$30.03bn in FY26E–28E turns FCF from +$6.22bn to −$12.85bn.
Concentration, bottlenecks & reporting
Geographic sales are anchored by the US and China, while battery supply is the binding physical constraint. In 3Q26 ($28,046m revenue), the US contributed $12,495m (44.6%), China $5,209m (18.6%) and rest-of-world $10,342m (36.9%). No single buyer exceeds 10% of revenue, but LFP cell imports exposed 2025–26 margins to tariff swings until the Feb 2026 Supreme Court IEEPA ruling triggered $447m net 3Q26 tariff refunds ($526m energy & $260m auto COGS credits less $339m owed to storage customers).
Management states passenger-car backlog is at a four-year high, with cell supply capping output. That bottleneck explains why Megapack growth (+30% in FY27E to 67.6 GWh as Megafactory Texas ramps) competes directly with vehicle packs until in-house cell and Terafab capacity scales later in the decade.
FY27E revenue rises 12.4% to $120.7bn across four engines, led by 30% storage and 140% FSD growth
Source: FY2025 Form 10-K; Penmark Research model
Source: Penmark Research model
Source: Penmark Research model
Source: Q3 FY2026 Form 10-Q; Signals geographic KPIs
Core cars earn $2.42k operating profit per unit, but $62.2bn of FY26E–30E venture capex drives negative FCF
Source: Company filings (A); Penmark Research estimates (E)
Source: Penmark Research model (FY27E hardware & allocated core opex per delivery)
Fixed versus variable cost structure
Separating variable factory costs from fixed AI/programme spend reveals a profitable core masked by pre-revenue ventures. In FY27E, variable vehicle manufacturing COGS absorbs 83.5% of hardware revenue ($34.83k per car on $41.71k ASP), leaving $6.88k hardware gross profit plus $0.18k of regulatory credits. Allocating core R&D (4.5% of revenue) and SG&A ex CEO award (6.3%) deducts $4.64k per delivery, leaving $2.42k ($5,762m across cars & services) of clean core EBIT.
Consolidated EBIT collapses to $774m (0.6% margin) only because fixed venture R&D ($7,648m) and CEO award SBC ($1,095m) sit on the income statement today. Within FY27E venture R&D, $3,500m is cash autonomy R&D, $1,500m cash programme R&D and $2,648m non-cash depreciation on programme compute and fab tooling.
Why estimated venture capex peaks at $30.0bn in FY28E
Management guided FY26 capex to ~$20bn (10-Q: “in excess of $20bn”) and flagged expanding multi-year spend for AI5/AI6 compute, Cybercab, Optimus and Terafab. We hold core automotive & storage capex at 8.0% of hardware/energy revenue ($8.3bn–$11.2bn in FY26E–30E) and layer an estimated $62.2bn of venture capex ($11.7bn FY26E, $15.5bn FY27E, $20.0bn FY28E, $10.0bn FY29E, $5.0bn FY30E).
Capex runs at 2.85x D&A in FY27E and 2.73x in FY28E, pushing programme assets to $43.7bn by end-FY28E. Under our modelled $25.0bn minimum liquidity rule (~2.2 months of FY28E revenue), cumulative FY26E–28E FCF of −$25.4bn requires drawing $6.81bn on Tesla’s $30.0bn credit facilities in FY28E before repaying in FY29E–30E.
Global EV sales topped 20m (+20%) and BESS hit 275 GWh (+61%) in 2025, while BYD overtook Tesla in BEV units
Source: Company filings; Signals KPIs; IEA; Waymo disclosures; Penmark Research
Source: IEA Global EV Outlook 2026; InfoLink Consulting BESS estimates
Source: Company production & delivery filings; BYD 2025 sales disclosures
Bottom-up market size, cycle & demand drivers
Global electric car volume exceeded 20m units in 2025 (+20% y/y, 25% of global light-vehicle sales), but regional growth is diverging sharply. China accounted for over 13m EVs (~55% new-car share) and Europe 4.2m (28% share), whereas North American EV affordability tightened after Congress repealed the US consumer EV tax credit in July 2025 and 10-year Treasury yields held at 5.15%. Against ~90m annual global car sales cited on calls, EV penetration is mid-S-curve.
Stationary battery storage is in structural hypergrowth on AI data-centre and grid demand. InfoLink estimates global BESS deployments rose 61.3% to 275.3 GWh in 2025 and reach 353.4 GWh in 2026E (US 2025 additions: 57.6 GWh per SEIA/Benchmark vs 52.1 GWh InfoLink; IEA tracks 108 GW of power capacity added, which is not interchangeable with GWh energy capacity).
Profit pools, share shifts & regulatory threats
Hardware margins are migrating toward lowest-cost Chinese cell-to-pack integrators, pushing Tesla toward software and grid profit pools. BYD grew pure-BEV passenger sales 27.9% in 2025 to 2,256,714 units, overtaking Tesla’s 1,636,129 deliveries (−8.6% y/y), and grew overseas shipments 67.8% in 1H26. In grid storage, cell price deflation pulled Tesla’s realised price from $321m/GWh (FY24A) to $234m/GWh (9M26A), though turnkey software (Autobidder) preserves ~26% clean gross margins vs loss-making integrators like Fluence (5% GM).
Autonomous ride-hailing remains city-by-city regulated. Waymo leads US commercial operations at ~500,000 paid rides/week across 15 cities with ~4,000 vehicles as of Sep 2026, proving technical viability while underscoring regulatory and fleet-support hurdles ahead of a Democratic Congress in Jan 2027.
Charging scale (84,465 connectors) and 75% NA FSD attach anchor Tesla’s moat, but BYD leads on cost and Waymo on paid rides
Source: Penmark Research model; Yahoo Finance as of 13 Nov 2026
Source: Penmark Research assessment from company filings & KPIs
| Arena | Key players / cohort | Customer choice criteria | Tesla rank & factual evidence | Durability / vulnerability |
|---|---|---|---|---|
| 1. Passenger EVs ($69.5bn FY25A) | BYD (2.26m BEVs), Toyota, GM, Ford; comparable to Rivian & Lucid. | Price/range, fast-charger access, residual value, ADAS software. | #2 global BEV volume (1.64m FY25A); #1 NACS network (84,465 connectors). 18.1% 3Q26 auto GM ex credits beats Western EV cohorts. | Chinese export ASPs (−$6.56/sh Bear 2 risk) & aging core lineup ex Model Y refresh. |
| 2. Grid & home BESS ($12.8bn FY25A) | CATL, Sungrow, BYD, Fluence Energy (1.42x EV/sales, 5% GM, Jun 26 10-Q). | Levelised cost/kWh, bankability, dispatch software, lead time. | Top-tier turnkey integrator (46.7 GWh FY25A; 36.0 GWh 9M26A). Megapack nearly sold out for 2027 as Megafactory Texas scales toward 50 GWh. | LFP tariff sensitivity; 3Q26 33.1% GM held $187m net refunds (~24% ex refunds, incl. warranty true-downs). |
| 3. Consumer ADAS / FSD (~$0.8bn FY26E) | Huawei ADS, XPeng/Xiaomi NOA, Mobileye, GM Super Cruise. | Door-to-door urban capability, monthly price ($99), regulatory legality. | #1 Western paid consumer base (1.74m subs; 75% NA attach in 3Q26). End-to-end neural net trained on multi-billion fleet miles & ~225 MW AI compute. | Supervised-only liability ceiling ($900/yr); EU/China regulatory delays & free Chinese ADAS. |
| 4. Autonomous ride-hailing (pre-rev) | Waymo (~4k AVs, 500k rides/wk; $126bn Feb 26 private round), Baidu, Uber. | Safety record, regulatory permits, wait time, cost per paid mile. | Challenger: hundreds of Austin/Bay Area cars (~2m unsupervised miles by 3Q26). Camera-only architecture targets lower vehicle capex ($30k) if safety holds. | $0.30/mi target not yet reached ($0.75/mi FY27E model); federal/state permit risk. |
Source: Company filings, Signals profile & KPIs, BYD, Waymo, Fluence FQ3 26 10-Q, Penmark Research model & assessment.
Source: Q3 FY2026 call & Signals KPI series
Why ecosystem switching costs last—and their limits
North America FSD attach jumping from 55% in 2Q26 to 75% in 3Q26 proves software pull inside Tesla’s hardware base. Standardisation on Tesla’s NACS plug, direct service integration and recurring software create high owner retention without dealer leakage.
Yet Musk noted in Nov 2025 that no other automaker wants to license FSD, capping software to Tesla’s own fleet. Unlike Waymo’s sensor-redundant city fleets or Uber’s multi-OEM demand aggregator, Tesla must self-fund every Cybercab ($57bn FY35E success-case capex) to capture mobility economics.
Musk holds 19.8% beneficial ownership with a 423.7m-share $2tn–$8.5tn award, while $62.2bn est. venture capex needs $6.8bn debt
| Governance item | Reported terms & Penmark model treatment |
|---|---|
| CEO & insider stake | Elon Musk beneficial ownership: 699.58m shares (19.8% at 30 Sep 2026 proxy); all directors & officers 20.0%. CFO: Vaibhav Taneja. |
| 2025 CEO stock award | 423.74m restricted shares across 12 tranches (35.31m each) vesting at $2.0tn–$8.5tn market-cap & operating milestones (8-K 7 Nov 2025). |
| Dilution & P&L impact | 0 tranches met at $1.54tn market cap; excluded from 3,544.0m diluted shares until met, while GAAP SG&A books $275m in 3Q26 ($1,095m/yr FY27E–34E). |
| Credit lines (Sep 26) | $30.0bn unsecured facilities signed 29 Sep 2026 ($20bn 3Y DDTL, $8bn 5Y rev., $2bn 364d rev.); $0 drawn in 2026, $6.81bn in FY28E. |
Source: DEF 14A proxy, Form 8-K (29 Sep 2026; 7 Nov 2025), Q3 10-Q, Penmark model.
| Date / entity | Disclosed transaction & governance assessment |
|---|---|
| 16 Jun 2026 (CEO) | Musk exercised 303.96m options at $23.34; 17.53m shares settled at $404.66 for strike/tax withholding (net +286.43m shares). |
| 8 Sep 2026 (CFO) | CFO Taneja sold 2,605.75 shares at $360.13 ($0.94m); no 10b5-1 flag in filing feed, which does not prove the sale was unplanned. |
| SpaceX ($2.0bn cost) | Bought ~$2.00bn SpaceX stock on 12 Mar 2026; $2.90bn fair value at 3Q26 (lock-up ends Dec 2026). FY25 rev $143.3m, exp $11.4m. |
| xAI & X Corp. | xAI revenue $430.1m in FY25 & $78.1m Jan–Feb 26 (Megapack sales), exp $4.0m FY25; X advertising $3.3m in FY25. |
Source: Signals Form 4 insider feed, DEF 14A related-party disclosures, Q3 2026 10-Q.
Source: Penmark Research model (4Q26E-FY28E cumulative)
| Management statement / guide | Period | Reported / Penmark | Assessment & implication for capital allocation |
|---|---|---|---|
| FY26 capex: >$20bn (Jan), >$25bn (Apr/Jul), ~$20bn (Oct) | FY26E | $13.01bn 9M26A; $20.01bn FY26E | Inside revised ~$20bn range: spend shifted into 4Q26E ($7.00bn) & FY27E–28E ($25.2bn / $30.0bn) as AI compute & Terafab ramp. |
| 2.6m annualised production run rate by end-2026 (Nov 25 AGM) | 3Q26A | 1.86m annualised (464.4k × 4) | Currently below 2.6m end-2026 target: reinforces caution on long-dated volume goals (~5m cars by 2030 vs our cell-constrained 2.43m FY30E). |
| No draws on $30bn credit facilities in 2026; zero dividends/buybacks | FY26E–28E | $0 draw FY26E–27E; $6.81bn FY28E | Confirmed for FY26E: zero shareholder payouts as 100% of OCF ($49.8bn FY26E–28E) plus cash/debt funds $75.2bn capex. |
| SpaceX combination press reports (12 Nov 2026; questions declined) | 12M | Not valued ($374.25 Hold check) | Governance watchpoint: at market value ($1.855tn SpaceX), a share swap alters paper ownership rather than Tesla operating value. |
Source: Q4 2025–Q3 2026 earnings calls, Form 8-K, Penmark Research model.
Idiosyncratic residual is 51% of weekly variance (after S&P/XLY); TSLA fell on 5 of 8 earnings days
Tesla trades on physical-AI optionality and multi-year investment shocks rather than current vehicle EPS. Across the last eight calls, autonomy and Optimus took 55.0% of analyst Q&A turns while margins and storage took 10.1%; yet on results days, opex and capex step-ups drove sell-offs (−14.5% in 2Q26, −3.1% in 3Q26), leaving a $91.53/sh gap between the $390.22 price and our $298.69 probability-weighted value.
| Driver | What moves the stock | Tests passed | Market reaction vs Penmark model value | Debate | Next number to watch |
|---|---|---|---|---|---|
| 1. Robotaxi & AV milestones | Unsupervised miles, city launches & federal AV policy shifts. | ●●●● All 4 tests | +8.9% 5-day rally (San Antonio launch, Nov 26); −10.8% on 5 Nov (Nasdaq −5.5%). Price implies $303.98/sh vs our $230.18/sh (+$73.80/sh, +32.1%). | Debate 1: Robotaxi scale | Dallas Cybercab & customer AVs (Nov 26–2Q27): 15k avg FY27E fleet (±$25.29/sh). |
| 2. Venture R&D & AI capex | Quarterly R&D/SG&A surprises & multi-year fab/AI capex guides. | ●●●○ Events, Ret., Var. | −14.5% on 2Q26 & −3.1% on 3Q26 as R&D jumped +69% y/y to $2.76bn. Model deducts −$12.85/sh PV and sits −28.1% vs FY27E EPS ($1.55 vs $2.16). | Debate 4: Core & capex | 4Q26 capex & FY27 guide (late Jan 27): we $7.00bn / $25.15bn vs ~$20bn FY26 guide. |
| 3. FSD attach, ARPU & EU | Paid FSD subscriber growth, attach rates & EU/China approvals. | ●●●○ Events, Ret., Q&A | Morgan Stanley credits $129.91/sh (not like-for-like: incl. insurance/charging) vs our $31.65/sh pure FSD net of $3.5bn/yr R&D (−$98.26/sh, −75.6%). | Debate 2: FSD software | FY26E paid FSD subs & EU (Jan–1Q27): we 1.95m subs after 75% NA attach. |
Source: Filings, Signals transcripts & KPIs, Yahoo Finance, Penmark model. Confirmed drivers pass ≥2 of 4 tests (events, returns, variance, Q&A).
Source: Yahoo Finance next-session closes after earnings releases
Source: Yahoo Finance closes to 13 Nov 2026
Source: Penmark Research model; Morgan Stanley public SOTP (*not like-for-like: incl. insurance/charging)
Autonomy took 44.9% of call Q&A turns (n=89), while delivery beats failed to hold results-day gains
Source: Yahoo Finance 3-year weekly OLS regression (n=156, R2=0.489)
Source: Signals transcripts (4Q24-3Q26, n=89 Q&A turns)
What the market does
AV headlines coincide with sharp multi-day swings. Shares fell 10.8% on 5 Nov (vs Nasdaq −5.5% amid AV oversight concerns), then rose 8.9% on 9–13 Nov (San Antonio launch); 44.9% of Q&A (40/89) focused on autonomy with hedged dates (“~2Q27”).
What our model says
Our four-outcome DCF credits robotaxi $230.18/sh ($805bn)—$118.19/sh above Morgan Stanley yet $73.80/sh below price-implied value. Clearing $390.22 needs $1,063bn (1.20x our 6.6m-car FY35E success path at certainty).
Debate and next number
Debate 1 (Robotaxi scale). Watch Dallas Cybercab (Nov–Dec 26) and unsupervised customer cars (~2Q27): we model 30k year-end FY27E fleet ($900m success rev); hitting or missing Q2 swings value ±$25.29/sh.
What the market does
Spend shocks punished 5 of 8 earnings days. TSLA fell 14.5% on 2Q26 and 3.1% on 3Q26 despite $0.48 non-GAAP EPS (aided by $447m net tariff refunds) as R&D surged 69% y/y to $2.76bn and 5Y GAAP EPS fell.
What our model says
Programme spend costs −$12.85/sh (−$44.9bn PV) and pulls FY27E non-GAAP EPS to $1.55 (−28.1% vs $2.16 consensus). Venture R&D reaches $9.89bn and total capex $30.03bn in FY28E, turning FY26E–28E FCF to −$25.4bn.
Debate and next number
Debate 4 (Core & capex). Watch 4Q26 capex and FY27E capex guide (late Jan 27): we forecast $7.00bn 4Q26E ($20.01bn FY26E) and $25.15bn FY27E; each +$2bn/yr R&D step-up trims $0.88/sh.
What the market does
Market SOTP estimates extrapolate 75% 3Q26 NA attach without deducting shared autonomy R&D. Over 3Y, TSLA rose +74.4% (+3.0pp vs S&P) on multiple expansion to 180.7x consensus forward P/E (249.6x Penmark FY26E) as FSD subs hit 1.74m.
What our model says
FSD is worth $31.65/sh ($110.7bn)—$98.26/sh (−75.6%) below Morgan Stanley’s $129.91/sh network mark (not like-for-like: incl. insurance, charging & licensing). Charging $3.5bn/yr of shared autonomy R&D keeps FSD FCF negative through FY28E (−$814m).
Debate and next number
Debate 2 (FSD software). Watch 4Q26 active subs (Jan 27; Penmark 1.95m) and EU FSD ruling (1Q27; +0.4m subs = +$0.73/sh); MS’s $130/sh FSD mark would flip our target to $443.06 (Buy).
| Candidate driver | Tests passed | Empirical & model reason it does not make the confirmed list |
|---|---|---|
| Quarterly EV delivery beats | ●○○○ Return (1/4) | 3Q26 beat (486.5k cars) still fell −3.1% next day; ±4pt annual delivery growth moves SOTP by just ±$3.6/sh. |
| Reported energy GM spikes | ●○○○ Partial (1/4) | 3Q26 hit 33.1% GM (+12.7pp q/q) on $187m net energy tariff refunds ($526m COGS less $339m rev.), yet stock fell −3.1%. |
| Isolated 10Y Treasury moves | ●○○○ Sector (1/4) | Rates hit auto affordability (−$1.31/sh) and 11.6% Ke, but add negligible weekly R² beyond S&P 500 + XLY (R²=0.489). |
Source: Signals KPIs, Q3 10-Q, Yahoo Finance, Penmark Research model.
What the market believes
Consensus models a smooth FY27E rebound ($2.16 non-GAAP EPS, +24.1% y/y), extrapolating 3Q26 margins without full AI capex/R&D P&L drag. Street FY26E EPS ($1.74 snapshot; live $1.72) implies ~$0.52 vs 9M26A $1.22 (live 4Q26E $0.50)—near 3Q26’s refund-boosted $0.48—while stale Jan–Apr 2026 EBITDA snapshots still show $19.91bn for FY27E.
The evidence (three independent sources)
- 1. Q3 10-Q & 8-K filings: 3Q26 GAAP EBIT ($718m, 2.6% margin) held $447m net IEEPA refunds ($526m energy & $260m auto COGS less $339m owed to storage customers) as R&D rose 69% y/y to $2,761m and SBC hit $1,165m.
- 2. Capex & credit filings: FY26 capex was guided to ~$20bn ($13.01bn in 9M26A) alongside $30.0bn unsecured credit lines signed 29 Sep 2026 for AI compute and Terafab.
- 3. Call guidance vs revisions: CFO Taneja guided rising multi-year opex and capex, yet FY27E consensus EPS drifted down just 3% over 90 days ($2.22 to $2.16).
Source: Company filings (A); Penmark Research estimates (E)
| $m, except EPS | FY25A | FY26E | FY27E | FY28E |
|---|---|---|---|---|
| Revenue, Penmark | 94,827 | 107,389 | 120,660 | 133,788 |
| Revenue, consensus (YF Nov 26) | 94,827 | 107,750 | 122,300 | n/a |
| Revenue gap vs consensus | — | −0.3% | −1.3% | — |
| Total R&D, Penmark (incl. venture) | 6,411 | 10,170 | 13,078 | 15,905 |
| Adj. EBITDA, Penmark | 14,596 | 13,773 | 14,328 | 17,357 |
| Adj. EBITDA, Jan–Apr 26 snapshot* | 14,596 | 15,084 | 19,907 | n/a |
| Non-GAAP EPS ($), Penmark | n/d | 1.56 | 1.55 | 1.66 |
| Non-GAAP EPS ($), consensus | n/d | 1.74 | 2.16 | n/a |
| EPS gap vs consensus | — | −10.2% | −28.1% | — |
| Free cash flow, Penmark | 6,220 | −1,947 | −10,582 | −12,848 |
Source: Filings, Yahoo Finance (14 Nov 26; live $1.72/$2.16), *MarketScreener (Jan–Apr 26, stale), Penmark model.
What it is worth
Isolating estimated programme spend (−$12.85/sh PV) and valuing cars/services ($12.76/sh) and storage ($7.31/sh) on clean cash flows puts core ex-FSD at $7.22/sh—$65.05/sh below Morgan Stanley’s broader core + energy lines. Across FY26E–28E, $75.2bn of capex ($47.2bn est. venture) lifts D&A from $6.15bn in FY25A ($6.86bn FY26E) to $11.00bn in FY28E, compressing GAAP EBIT margin from 1.9% (FY26E) to 0.6%–0.9% (FY27E–28E) and cutting net cash from $35.9bn to $8.7bn.
Dated signposts
- Late Jan 2027 (4Q26 results): Confirms if 4Q26 capex hits ~$7.0bn, non-GAAP EPS dips toward $0.34 ex refunds, and FY27E capex is guided ≥$24bn.
- Apr & Jul 2027 (1H27 10-Qs): Confirms if quarterly R&D tops $3.1bn ($13.1bn FY27E pace) ahead of FY28E facility draws.
Source: Company filings (A); Penmark Research estimates (E)
Source: Company filings (A); Penmark Research estimates (E)
What the market believes
Holding non-robotaxi pillars at base ($86.24/sh, or $301.6bn equity at Sep 26), $390.22 embeds $303.98/sh ($1,063.1bn) for robotaxi. At $1.00/mi mature price, $0.28/mi opex and $30k capex/car, the price requires 7.93m robotaxis by FY35E at 100% certainty—8.4x Waymo’s reported $126bn Feb 2026 private round.
The evidence (three independent sources)
- 1. Q2–Q3 call disclosures: Austin/Bay Area cars remain in the hundreds (~2m unsupervised miles); noticeable revenue starts ~2Q27 and cost/mile exceeds the $0.30/mi target.
- 2. Industry & policy reality: Waymo runs ~4k AVs across 15 cities (~500k rides/wk) as of Sep 2026, highlighting city permitting ahead of a Democratic Congress in Jan 2027.
- 3. Fleet capex physics: Our analyst-set 6.6m-car FY35E success path burns $13.47bn FCF in FY27E–30E and needs $57.0bn/yr fleet capex by FY35E (62.9% terminal value share).
Source: Waymo disclosures (Sep 2026); Q3 call; Penmark Research model (vehicles in thousands)
| Venture outcome (analyst-set) | Mult. | Prob. | Sep 26 ($bn) | Base ($/sh) |
|---|---|---|---|---|
| Robotaxi (success = 6.6m cars, $300bn rev FY35E) | ||||
| Failure (supervised only) | 0.00x | 10% | 0.0 | 0.00 |
| Niche (regional approved roads) | 0.05x | 20% | 44.2 | 12.65 |
| Success (unrisked path) | 1.00x | 50% | 884.7 | 252.95 |
| Dominant (2x success scale) | 2.00x | 20% | 1,769.3 | 505.90 |
| Robotaxi wt. / Price-implied | 0.91x | 100% | 805.0 | 230.18 / 303.98 |
| Optimus (success = 8.0m units FY40E, net of $2.3bn dev PV) | ||||
| Fail (20%) & Niche 0.15x (30%) | — | 50% | 7.7 wt | 2.20 wt |
| Succ. 1x (35%) & Dom. 2x (15%) | — | 50% | 120.1 wt | 34.34 wt |
| Optimus probability-weighted | 0.69x | 100% | 127.8 | 36.54 |
Source: Penmark Research model. 6.6m robotaxi & 8.0m Optimus paths are analyst-set assumptions.
What it is worth
We credit robotaxi at $230.18/sh ($805bn) and Optimus at $36.54/sh ($128bn)—$118.19/sh above Morgan Stanley ($111.99/sh, 30k cars in 2030)—rolling our base case to a $353.18 12m target (−9.5%, Hold) and weighted call to $333.38 (−14.6%, Sell). Using Morgan Stanley’s mobility mark cuts our target to $201.46 (−48.4%, Sell).
Dated signposts
- Nov–Dec 2026 (Dallas Cybercab): Paid driverless rides in Texas metro #3 after Austin and San Antonio.
- 2Q 2027 (Customer unsupervised FSD): Retail cars entering network (±$25.29/sh) vs NHTSA/Congressional permit delays (−$25.29/sh).
Source: Penmark Research model (unrisked success path)
Source: Penmark Research model (base SOTP rolled 12m at 11.62% Ke)
What the market believes
Third-party SOTP frameworks value FSD/network services up to $129.91/sh ($145 target; broader scope incl. insurance & charging) and Energy up to $35.84/sh ($40 target) without deducting shared AI R&D or 3Q26’s one-off tariff refunds.
The evidence (three independent sources)
- 1. Signals FSD KPIs & OEM reality: Active subs hit 1.74m in 3Q26 (+67% y/y; 75% NA attach), yet FY26E FSD revenue is ~$800m and Musk confirmed no OEM wants to license FSD ($0 third-party line).
- 2. 3Q26 Energy margin bridge: Reported 33.1% energy GM held $187m net IEEPA refunds ($526m COGS less $339m owed to storage customers; ~24% ex refunds, still incl. unquantified warranty true-downs) as $/GWh fell 27% from $321m (FY24A) to $234m (9M26A).
- 3. R&D & peer discipline: Fluence trades at 1.42x EV/sales (5% GM, Jun 2026 10-Q); charging FSD $3.5bn/yr of shared autonomy R&D (−$25.9bn PV) cuts FSD by $7.41/sh and keeps FCF negative to FY28E.
Source: Penmark Research model (FSD outcomes)
| FSD & Energy build | Prob/25A | FY27E | FY30E | $/sh |
|---|---|---|---|---|
| FSD outcomes (10m base subs FY34E; net of $3.5bn/yr R&D) | ||||
| Failure ($900/yr cap) | 10% | −$2,056m | −$907m | 1.29 |
| Niche ($2,200/yr roads) | 20% | −$1,727m | +$1,295m | 19.66 |
| Success ($3,600/yr AV) | 50% | −$1,602m | +$3,558m | 38.62 |
| Dominant ($4,200/yr) | 20% | −$1,640m | +$3,844m | 41.38 |
| FSD wt. (pre-R&D $39.06) | 100% | $1,921m rev | $9,920m rev | 31.65 |
| Energy storage (normalised ex 3Q26 refunds) | ||||
| GWh / Price ($m/GWh) | 46.7/$273 | 67.6/$234 | 107.1/$221 | — |
| Energy GM / Pillar DCF | 29.8% | 26.0% | 26.0% | 7.31 |
Source: Filings, Signals KPIs, Penmark model (FCF in $m for FSD rows).
What it is worth
On a 12-month target basis, doubling FSD subs (20m) or ARPU lifts our base target to $394.57–$394.69 (+1.1%, Hold), while +4pt Energy GM reaches $355.57 (−8.9%, Hold). Cutting WACC by 100bp lifts our weighted target to $399.32 (+2.3%, Hold); reaching Buy (>$429.24) requires Morgan Stanley’s $129.91/sh network mark ($443.06 target, +13.5%), setting Low conviction.
Dated signposts
- 1Q 2027 (EU FSD ruling): Tests non-US FSD approval (+0.4m subs = +$0.73/sh) vs regulatory ceiling.
- 1Q–2Q 2027 (Energy GM ex refunds): Tests whether Megapack GM settles at 24–26% once 3Q26’s $187m net energy refunds and unquantified warranty true-downs roll off.
Source: Company filings (A); Penmark Research estimates (E)
Source: Penmark Research model (12m target $/sh; MS public SOTP)
GAAP operating margin fell from 16.8% (FY22A) to 2.6% (9M26A), while 3Q26 non-GAAP NI was 2.16x GAAP
| $m, except EPS, k, GWh | FY21A | FY22A | FY23A | FY24A | FY25A | 9M26A |
|---|---|---|---|---|---|---|
| Total revenues | 53,823 | 81,462 | 96,773 | 97,690 | 94,827 | 78,669 |
| Revenue growth y/y | +70.7% | +51.4% | +18.8% | +0.9% | −2.9% | +12.5% |
| Deliveries (k) / BESS (GWh) | 936 / 4.0 | 1,314 / 6.5 | 1,809 / 14.7 | 1,789 / 31.4 | 1,636 / 46.7 | 1,325 / 36.0 |
| Gross / GAAP EBIT margin | 25.3% / 12.1% | 25.6% / 16.8% | 18.2% / 9.2% | 17.9% / 7.2% | 18.0% / 4.6% | 19.0% / 2.6% |
| GAAP NI / Diluted EPS ($) | 5,519 / 1.63 | 12,556 / 3.62 | 14,997 / 4.30 | 7,091 / 2.04 | 3,794 / 1.08 | 2,378 / 0.67 |
| OCF / Free cash flow | 11,497 / n/d | 14,724 / n/d | 13,256 / 4,357 | 14,923 / 3,581 | 14,747 / 6,220 | 14,897 / 1,883 |
| FCF/NI conv. / ROE (avg eq.) | n/d / 21.1% | n/d / 33.5% | 29.1% / 27.9% | 50.5% / 10.5% | 163.9% / 4.9% | 79.2% / 3.7% |
Source: FY2021–FY2025 Form 10-K, Q3 2026 Form 10-Q, Penmark Research model (9M26A ROE annualised). FY23A GAAP NI included a $5.9bn tax valuation-allowance release.
Source: Company filings (A); Penmark Research estimates (E)
Source: Company quarterly updates & Form 10-Q (2Q25-3Q26)
| Item | Reported accounting & cash impact | Status |
|---|---|---|
| SBC & 2025 CEO award | 9M26A SBC hit $3,346m (30.9% of $10,841m Adj. EBITDA), incl. $275m 3Q26 CEO award. Model treats 3% employee SBC as cash cost. | Flag |
| 3Q26 tariff & warranty | $447m net IEEPA refunds ($526m energy & $260m auto COGS less $339m energy rev. = $187m net energy) plus unquantified warranty true-downs lifted 3Q26 EBIT ($718m) & energy GM (33.1% vs ~24% ex refunds). | Flag |
| Zero-cost reg. credits | 100%-margin credits fell from $2,763m (FY24A) to $1,993m (FY25A) and $639m (9M26A); modelled at $350m FY27E & $150m FY29E+. | Watch |
| Deferred rev. & leases | $4,660m 3Q26 deferred rev. is cash-collected upfront; operating lease cost sits in opex, avoiding EV double count. | Clean |
Source: Q3 2026 10-Q, Signals, Penmark model.
Our read on reported profit quality
Reported non-GAAP EPS ($1.22 in 9M26A; $0.48 in 3Q26) overstates recurring economic profit because it adds back $3.35bn of ongoing SBC while retaining $447m of net 3Q26 tariff refunds. In our DCF, employee SBC (3.0% of revenue) is expensed as a real economic cost and the 2025 CEO award ($1,095m/yr) is added back to NOPAT only because tranche dilution is tested directly in share count.
Revenue compounds at 11.1% (FY25A–30E) to $160.7bn, but venture spend puts FY27E EPS 28.1% below consensus
| Operating & cost drivers | FY24A | FY25A | FY26E | FY27E | FY28E | FY29E | FY30E |
|---|---|---|---|---|---|---|---|
| Vehicle deliveries (k) | 1,789.2 | 1,636.1 | 1,804.7 | 1,985.1 | 2,144.0 | 2,294.0 | 2,431.7 |
| Delivery growth y/y | −1.1% | −8.6% | +10.3% | +10.0% | +8.0% | +7.0% | +6.0% |
| Hardware ASP ex FSD ($k) | 41.5* | 41.3* | 42.1 | 41.7 | 41.7 | 41.7 | 41.7 |
| Paid FSD subs, end (m) | n/d | 1.10 | 1.95 | 2.80 | 3.70 | 4.70 | 5.80 |
| Wt. FSD software rev. ($m) | n/d | n/d | 800 | 1,921 | 3,502 | 6,052 | 9,920 |
| Storage deployed (GWh) | 31.4 | 46.7 | 52.0 | 67.6 | 82.5 | 95.7 | 107.1 |
| Energy rev. ($m) / GM (%) | 10,086/26% | 12,771/30% | 12,188/29% | 15,844/26% | 18,944/26% | 21,535/26% | 23,637/26% |
| Services & other rev. ($m) | 10,534 | 12,530 | 17,631 | 19,747 | 21,721 | 23,676 | 25,570 |
| Core / Venture R&D ($bn) | 4.4 / 0.1 | 4.3 / 2.1 | 4.8 / 5.3 | 5.4 / 7.6 | 6.0 / 9.9 | 6.6 / 10.6 | 7.2 / 10.3 |
| Core / Venture capex ($bn) | 11.3 tot | 8.5 tot | 8.3 / 11.7 | 9.7 / 15.5 | 10.0 / 20.0 | 10.3 / 10.0 | 11.2 / 5.0 |
Source: Filings (A), Signals KPIs, Penmark estimates (E; *FY24A–25A ASP incl. FSD; 9M26A: 1,325k cars, 36.0 GWh, 1.74m subs).
| Metric ($m / $) | Period | Penmark | Cons. | Guide | Gap | Analytical reason for the gap |
|---|---|---|---|---|---|---|
| Revenue | 26E/27E | 107.4/120.7b | 107.8/122.3b | None | −0.3/−1.3% | +10% FY27E deliveries (cell-capped) & +30% storage match Street top line (live YF $107.9b/$122.4b). |
| Gross margin | 26E/27E | 18.8%/18.7% | ~19.5% imp | BESS up | −0.8pp | Strip $447m net 3Q26 tariff refunds ($187m net energy; 26% FY27E GM) & model 16.5% hardware GM on Chinese exports. |
| Adj. EBITDA | 26E/27E | 13,773/14,328 | 15,084/19,907* | Opex up | −8.7/−28.0% | *MarketScreener snapshot (Jan–Apr 26) predates 2Q/3Q R&D surge (+69% y/y); $5.0bn cash venture R&D. |
| Non-GAAP EPS | 26E/27E | 1.56 / 1.55 | 1.74 / 2.16 | None | −10.2/−28.1% | 4Q26E drops to $0.34 ex 3Q refunds; FY27E D&A rises +$1.98bn to $8.84bn on $25.2bn capex (live YF $1.72/$2.16). |
| Capex | 26E/27E | 20,014/25,153 | ~20,000/n/d | ~$20bn | In guide | Matches ~$20bn FY26 call guide (>$20bn 10-Q), then steps up for AI5/AI6, Cybercab & Terafab. |
| Free cash flow | 26E/27E | −1,947/−10,582 | Pos. imp | No 26 draw | Deficit | $14.57bn FY27E OCF falls $10.58bn short of $25.15bn capex (−$14.20bn FCF after employee SBC). |
Source: Yahoo Finance (14 Nov 26; live), *MarketScreener (Jan–Apr 26, stale), Q3 10-Q & call, Penmark model.
Core margin sensitivity is muted (−$5.6 to +$9.8/sh), while negative FY26E–28E FCF draws $6.81bn of credit in FY28E
Source: Penmark Research model
Source: Company filings (A); Penmark Research estimates (E)
Reasoning for each revenue & margin path
Vehicle deliveries (+10.3% FY26E, +10.0% FY27E, tapering to +6.0% in FY30E = 2.43m units): Passenger-car backlog sits at a four-year high, but cell supply caps output and installed car capacity is ~2.35m units. Unlike management’s ~5m 2030 ambition, we cap core deliveries near existing factory expansion and hold hardware ASP flat at $41.7k as affordable trims offset mix.
Energy storage (+30.0% FY27E to 67.6 GWh; 107.1 GWh FY30E at 26.0% GM): Megafactory Texas (50 GWh planned) and near-sold-out 2027 Megapack demand drive volume, while LFP competition nudges $/GWh down 2%/yr from FY28E and strips 3Q26’s refund spike.
FSD software (1.95m subs FY26E to 5.80m FY30E; $809 to $1,890 wt. ARPU): Probability-weighted across our four autonomy outcomes, FSD revenue scales from ~$800m (FY26E) to $1,921m (FY27E) and $9,920m (FY30E) at ~81% gross margin after crash-liability accruals.
Fixed vs variable costs, working capital & funding
Core vs venture cost split: Core R&D (4.5% of sales) and SG&A ex CEO award (6.3% in FY27E, scaling to 5.7% in FY30E) grow with revenue, whereas fixed cash venture R&D ($5.0bn–$5.5bn/yr) plus programme D&A ($2.65bn FY27E to $5.82bn FY30E) depresses near-term EBIT before tapering as ventures commercialise.
Cash, working capital & balance-sheet bridge: Working capital investment absorbs a modest ~$530m/yr ($531m FY27E, $525m FY28E) thanks to direct-sale payables and FSD deferred revenue. However, total capex of $20.01bn (FY26E), $25.15bn (FY27E) and $30.03bn (FY28E) pulls cash from $45.45bn (3Q26A) to our $25.00bn liquidity floor in FY28E, triggering a $6.81bn draw on the $30.0bn Sep 2026 facilities (pushing debt from $9.52bn to $16.34bn and net cash down to $8.66bn) before positive FY29E–30E FCF ($0.53bn / $8.88bn) repays the draw in full.
Primary SOTP values TSLA at $316.42/sh (base) and peer P/E cross-check at $269.02/sh (−15.0%)
Source: Penmark Research model (at 13 Nov 2026 price date)
Source: Penmark Research model; FactSet / Yahoo Finance Street targets
Source: Penmark Research model
| Valuation pillar / bridge line | Method & key assumption | Sep 26 ($m) | $/sh | Share |
|---|---|---|---|---|
| Auto hardware, credits & services | 14Y DCF (FQ4 26E–FY40E), 17.5% mature GM, 3% g | 44,631 | 12.76 | 4.0% |
| Energy generation & storage | 14Y DCF, 26.0% clean GM, 107 GWh FY30E, 3% g | 25,549 | 7.31 | 2.3% |
| FSD software (net of $3.5bn R&D) | 4-outcome DCF (10m base subs; $39.06 pre-R&D) | 110,681 | 31.65 | 10.0% |
| Estimated programme spend | PV of programme R&D & $62.2bn est. capex (run-off) | −44,939 | −12.85 | −4.1% |
| Core enterprise value | Matches consolidated Core DCF (62.3% TV share) | 135,922 | 38.86 | 12.3% |
| Robotaxi (4 outcomes, analyst) | 0.91x of $884.7bn 6.6m-car FY35E success DCF | 805,035 | 230.18 | 72.7% |
| Optimus (4 outcomes, analyst) | 0.69x of $184.2bn 8.0m-unit FY40E success DCF | 127,800 | 36.54 | 11.5% |
| Net cash, SpaceX, NCI & litig. | $35.92bn net cash + $2.90bn SpaceX − $0.93bn NCI/lit. | 37,895 | 10.84 | 3.4% |
| Primary base SOTP equity | 3,544.0m sh; rolled 44d at 11.62% Ke (1.0133x) | 1,106,652 | 316.42 | 100.0% |
| Cross-check: 6.13x peer P/E | 6.13x FY28E core NI ($5.4bn) − $58.7bn venture PV + vent. | 940,859 | 269.02 | −15.0% |
Source: Penmark Research model; Yahoo Finance. CAPM: 5.15% Rf + 1.525 beta × 4.24% Damodaran ERP = 11.62% Ke (11.57% WACC).
Scenario weighting yields $298.69/sh and a $333.38 12m target (−14.6%, Sell), with Low conviction on six flips
Source: Penmark Research model (price-date scenario values)
Source: Penmark Research model; Morgan Stanley public SOTP
| Scenario / line | Prob. | Key operating & venture assumptions | Val ($) | Tgt ($) | Ret. | Call |
|---|---|---|---|---|---|---|
| Bear case | 30% | +2% FY27E cars, 14% hw GM, 21% BESS GM; 7.5m FSD; robotaxi 25% fail/35% succ; Opt. 45% fail. | 175.48 | 195.86 | −49.8% | Sell |
| Base case | 50% | +10% FY27E cars, 16.5–17.5% hw GM, 26% BESS GM; 10m FSD; robotaxi 10% fail/70% succ+dom. | 316.42 | 353.18 | −9.5% | Hold |
| Bull case | 20% | +16% FY27E cars, 18.5–19.5% hw GM, 29% BESS GM; 21m FSD; robotaxi 5% fail/35% dom; Opt. 25% dom. | 439.16 | 490.18 | +25.6% | Buy |
| Weighted / Target | 100% | $298.69 × (1 + 11.616% Ke), $0 div.; 214.7x FY27E non-GAAP P/E at target (251.4x at $390.22) | 298.69 | 333.38 | −14.6% | Sell |
Source: Penmark Research model. Unrounded return: ($333.3839 / $390.22) − 1 = −14.565% (Sell: <−10.0%). Subjective scenario weights carry wide bounds.
| Reverse-DCF / robustness | Implied or alternative input | Val ($) | Tgt ($) | Ret. | Rating |
|---|---|---|---|---|---|
| Implied robotaxi ($390.22) | Needs $1,063.1bn ($303.98/sh) = 1.20x success path (7.93m FY35E AVs at certainty) | 390.22 | — | 0.0% | Price |
| Implied Core EV / Term. g | Needs 2.90x model Core EV ($394bn); max g at WACC−1pt (10.57%) gives $312.80 | 312.80 | — | — | Below |
| WACC −1.0pt / Beta 1.31 | 100bp lower WACC or 1.31 relevered peer beta lifts 12m target into Hold band | 361 / 355 | 399 / 393 | +2.3/+0.6% | Hold |
| MS FSD / All MS lines* | MS network services ($129.91/sh) flips to Buy; all MS lines ($415 tgt) give Hold | 397 / 354 | 443 / 395 | +13.5/+1.3% | Buy/Hold |
| SpaceX market-ratio deal | Paper swap at $1.855tn SpaceX mark (not operating value) shifts target to Hold | 335.30 | 374.25 | −4.1% | Hold |
Source: Penmark Research model; *Morgan Stanley public SOTP (not like-for-like: network services incl. insurance/charging). Base case alone ($353.18 target, −9.5%) also lands in Hold.
Eight dated catalysts over the next 14 months test our EPS gap and ±$25.29/sh autonomy probabilities
| Date | Event | Penmark expectation | Consensus / market view | Unrisked $/sh & mechanism | Rating impact |
|---|---|---|---|---|---|
| Nov–Dec 26 | Dallas Cybercab launch | Pilot fleet in hundreds; supervised backup in edge cases. | Priced as smooth multi-city scale-up after San Antonio (+8.9%). | Part of Bull 1 (+$25.29/sh if paired with Q2 customer AVs). | Neutral |
| Dec 2026+ | SpaceX lock-up & deal talk | $2.9bn stake lock-up expires; no operating value creation. | Speculative premium after 12 Nov Bloomberg merger report. | Market-ratio swap tests $374.25 Hold on paper mix only. | Could flip Hold |
| Late Jan 27 | 4Q26 results & FY27 capex | Rev $28.72bn, non-GAAP EPS $0.34, capex $7.00bn; FY27E capex ~$25bn. | Implied rev ~$29.1bn (YF $29.3bn), EPS $0.50–$0.52. | Exposes ~$0.10/sh 3Q refund roll-off & Bear 1 (−$0.88/sh). | Supports Sell |
| Jan–Jun 27 | 120th Congress AV oversight | Tighter NHTSA reporting & scrutiny of 2,500-car exemption cap. | 5 Nov −10.8% drop (vs Nasdaq −5.5%) partly retraced 9–13 Nov. | Bear 3: −10pt robotaxi success prob. = −$25.29/sh (30% prob). | Supports Sell |
| 1Q 2027 | EU-wide FSD ruling | Conditional supervised approval; gradual attach outside NA. | Musk expects approval by 1Q27; high SaaS multiple. | Bull 3: +0.4m FY27E FSD subs = +$0.73/sh (50% prob). | Neutral |
| 1Q–2Q 27 | Energy GM ex IEEPA refunds | Energy GM normalises to 25–26% as $187m net 3Q26 energy refunds end. | 33.1% 3Q26 energy GM widely extrapolated. | Bear 4 (−4pt GM = −$1.67/sh) vs Bull 4 (+1pt car GM = +$2.19/sh). | Supports Sell |
| 2Q 2027 | Unsupervised customer AVs | Limited geo-fenced rollout; noticeable revenue slips past 2Q27. | Management guides noticeable robotaxi P&L impact ~2Q27. | Bull 1: +10pt robotaxi success = +$25.29/sh (40% prob). | Could flip Hold |
| Apr–Dec 27 | Megafactory TX & Optimus | 67.6 GWh FY27E storage; pilot external Optimus deliveries late 27. | 50 GWh TX ramp & AI5/Optimus commercial scale priced in. | Bull 2 (+12 GWh = +$1.93/sh); Bull 5 (+5pt Opt. = +$2.63/sh). | Neutral |
Source: Q3 2026 10-Q & call, Yahoo Finance, Penmark Research model.
Source: Q3 2026 Update & call; Penmark Research model
| Section 9 driver | Next number & date | Penmark vs consensus | Exact threshold that changes our Sell rating |
|---|---|---|---|
| 1. Robotaxi & AV scale | Active unsupervised AVs & $/mi (2Q27 call, Jul 27) | 15k avg / 30k end-FY27E success fleet; $0.75/mi FY27E vs $0.30/mi goal. | Hold band (−10% to +10%): Target $351.20–$429.24 at $390.22 (or share price $303.07–$370.42 at our $333.38 target). |
| 2. Venture R&D & capex | 4Q26 capex & R&D (late Jan 27 release) | $7.00bn capex, $3.09bn R&D, $0.34 non-GAAP EPS vs $0.50–$0.52 Street. | Buy boundary (>+10.0%): Target >$429.24 at $390.22 (or share price <$303.07 at our $333.38 target). |
| 3. FSD subs & ARPU | Year-end paid FSD subs (late Jan 27) & EU ruling | 1.95m end-FY26E subs (vs 1.74m 3Q26); ~$800m FY26E FSD rev. | Adopting MS’s $129.91/sh network mark lifts target to $443.06 (+13.5%, Buy). |
Source: Signals KPIs, Yahoo Finance, Penmark Research model (rating rule: Buy >+10%, Hold −10% to +10%, Sell <−10%).
For our Sell call, upside autonomy execution (+$25.29/sh) and WACC shifts pose the main rating risks
| Risk (direction vs Sell) | Mechanism & scenario impact | Prob. | Unrisked $/sh | Observable signpost to watch |
|---|---|---|---|---|
| Bull 1: Q2 customer AVs (Upside risk to Sell) | Dallas Cybercab scales cleanly & retail owners deploy unsupervised FSD in 2Q27 (+10pt robotaxi success from failure). | 40% | +$25.29 | NHTSA/state driverless permits & removal of remote safety monitors by Jun 2027. |
| Bull 5: Optimus & AI5 (Upside risk to Sell) | AI5 chip enters Optimus ~Apr 2027 & paid external factory shipments start late 2027 (+5pt Optimus success). | 30% | +$2.63 | Third-party industrial purchase orders & Fremont humanoid yield disclosures. |
| Bull 4 & 2: Tariffs & TX BESS (Upside to Sell) | Lower inbound duties lift FY27E car GM +1pt (+$2.19/sh, 50% prob); Megafactory TX adds +12 GWh (+$1.93/sh, 40% prob). | 40–50% | +$4.12 comb. | 1H27 automotive ex-credit GM >18.5% & quarterly BESS deployments >18 GWh. |
| WACC / Street FSD re-rate (Model risk to Sell) | −100bp WACC lifts target to $399.32 (Hold); MS FSD valuation ($129.91/sh) lifts target to $443.06 (Buy). | Low conv. | +$65.94 target | 10Y Treasury falling below 4.15% or OEM FSD licensing deals (currently $0). |
| Bear 3: Congressional AV (Downside to target) | Democratic Congress (from Jan 2027) tightens federal AV rules & Musk-company oversight (−10pt robotaxi success). | 30% | −$25.29 | House/Senate AV hearing subpoenas or NHTSA recall restrictions in 1H27. |
| Bear 2, 4, 5 & 1: Core (Downside to target) | Chinese export ASP −3% (−$6.56/sh), energy GM −4pt ex refunds (−$1.67), 5% rates (−$1.31), R&D +$2bn/yr (−$0.88). | 35–50% | −$10.42 comb. | BYD EU/ROW share gains, 1Q27 energy GM <24%, & quarterly R&D >$3.3bn. |
Source: Q3 2026 Form 10-Q & call, Penmark Research model (net probability-weighted catalyst/risk skew: +$1.44/sh).
What would end our Sell thesis
Our Sell call ends if probability-weighted 12-month target upside crosses −10.0% ($351.20 target at $390.22, or a $303.07–$370.42 share price at our $333.38 target). Operationally, commercial unsupervised FSD in customer cars by 2Q27 without safety incidents (+$25.29/sh unrisked) combined with disciplined FY27E capex (<$20bn) would lift our weighted target into Hold ($351–$429) or Bull ($490.18).
Regulatory & product-liability risks
Autonomous vehicles face federal FMVSS limits (2,500-car exemption cap for pedal-free Cybercabs) and tort liability. We deduct $329m in our EV bridge for the appealed Benavides Autopilot verdict ($129m compensatory + $200m punitive, FY25 10-K) and expense $80m–$661m/yr of FSD crash liability in FY27E–31E.
Key-person, governance & related-party risks
Tesla’s AI valuation is uniquely tied to CEO Elon Musk (19.8% holder), who simultaneously leads SpaceX, xAI and X Corp. Related-party links deepened in 2025–26 via $430.1m of FY25 xAI Megapack sales and Tesla’s $2.0bn SpaceX investment.
Two governance overhangs matter for per-share value: (1) the 423.7m-share 2025 CEO award (~10.7% potential dilution if $2.0tn–$8.5tn milestones are met, while costing $1,095m/yr in GAAP SG&A today); and (2) potential SpaceX merger terms, where any off-market exchange ratio could dilute TSLA holders (at market prices, it alters paper mix to $374.25 Hold).
Insiders hold 20.0%, short interest sits at 1.75 days to cover (66.0m shares), and 44% of Street ratings are Buy
| Institution (Q2 2026 13F) | Shares (m) | % S/O* | Δ (m) | Δ % |
|---|---|---|---|---|
| Vanguard Group | 263.37 | 6.67% | +2.22 | +0.85% |
| BlackRock | 214.12 | 5.42% | +5.99 | +2.88% |
| State Street | 117.46 | 2.97% | +2.76 | +2.41% |
| Geode Capital Mgmt | 68.91 | 1.74% | +0.91 | +1.34% |
| Invesco | 55.46 | 1.40% | +17.52 | +46.17% |
| Capital World Investors | 45.74 | 1.16% | +2.83 | +6.60% |
| JPMorgan Chase | 41.97 | 1.06% | −4.10 | −8.90% |
| FMR (Fidelity) | 39.77 | 1.01% | +3.74 | +10.38% |
| Morgan Stanley | 38.87 | 0.98% | −0.31 | −0.78% |
| Norges Bank Inv. Mgmt | 38.81 | 0.98% | n/d | n/d |
| Reported 13F (4,262)* | 1,677.14 | 42.46% | — | — |
Source: Signals 13F feed (30 Jun 2026). *42.46% of 3,949.55m shares; incomplete non-13F coverage (Sep 26 proxy lists Vanguard at 5.3%).
Source: Signals biweekly short-interest filings to 30 Oct 2026
Source: FactSet / Yahoo Finance public consensus & broker targets (13-14 Nov 2026); Penmark model
| 3M avg. daily volume / value | 37.72m sh / $13,905.9m |
| 52-week intraday / close | $297.38–$498.83 / $298.32–$489.88 |
| Shares out (15 Oct 2026) | 3,952.76m (incl. 423.74m unearned) |
| Diluted shares modelled | 3,544.01m (ex unearned CEO award) |
| Insider beneficial stake | 20.0% (Musk 699.58m / 19.8%) |
| Short interest (30 Oct 26) | 65.96m sh (1.75x 3M vol; 1.57 feed) |
| Index membership | S&P 500, Nasdaq-100, Russell 1000 |
| Street ratings (43) | 19 Buy (44%), 20 Hold (47%), 4 Sell (9%) |
| Street 12m target range | $416.26 mean ($24.86 to $600.00) |
| Lock-ups & overhangs | SpaceX $2.9bn lock-up Dec 26; 423.7m award |
Source: Signals, Q3 10-Q, Yahoo Finance, Penmark model.
Who sets the marginal share price
At $13.9bn average daily turnover and 1.75 days to cover on 3M volume (1.57 in FINRA’s settlement feed), TSLA is priced by AI/options flow rather than short-squeeze risk. Passive index funds anchor core ownership while growth funds trade autonomy milestones.
Insider activity & dilution overhangs
Musk’s June 2026 exercise of 303.96m options at $23.34 (17.53m withheld at $404.66) lifted his beneficial stake to 19.8%. CFO Taneja’s $0.94m Sep 2026 sale carried no 10b5-1 flag (not proof it was unplanned); 423.7m 2025-award shares stay unearned below $2.0tn.
Annual consolidated statements (FY24A–FY30E): GAAP EBIT troughs at $774m in FY27E before FSD inflects
| $m, Dec year-end | FY24A | FY25A | 9M26A | FY26E | FY27E | FY28E | FY29E | FY30E |
|---|---|---|---|---|---|---|---|---|
| Income statement | ||||||||
| Automotive revenues (incl. credits & FSD) | 77,070 | 69,526 | 57,310 | 77,570 | 85,069 | 93,123 | 101,883 | 111,492 |
| Energy generation & storage revenue | 10,086 | 12,771 | 8,428 | 12,188 | 15,844 | 18,944 | 21,535 | 23,637 |
| Services & other revenue | 10,534 | 12,530 | 12,931 | 17,631 | 19,747 | 21,721 | 23,676 | 25,570 |
| Total revenues | 97,690 | 94,827 | 78,669 | 107,389 | 120,660 | 133,788 | 147,095 | 160,699 |
| Revenue growth y/y | +0.9% | −2.9% | +12.5% | +13.2% | +12.4% | +10.9% | +9.9% | +9.2% |
| Gross profit | 17,450 | 17,094 | 14,965 | 20,137 | 22,548 | 26,413 | 30,926 | 35,874 |
| Gross margin | 17.9% | 18.0% | 19.0% | 18.8% | 18.7% | 19.7% | 21.0% | 22.3% |
| Research & development (core + venture) | 4,540 | 6,411 | 7,078 | 10,170 | 13,078 | 15,905 | 17,225 | 17,555 |
| SG&A (incl. $1,095m/yr CEO award FY27E+) & restruc. | 5,834 | 6,328 | 5,830 | 7,914 | 8,697 | 9,256 | 9,774 | 10,255 |
| Income from operations (GAAP EBIT) | 7,076 | 4,355 | 2,057 | 2,052 | 774 | 1,252 | 3,928 | 8,064 |
| GAAP operating margin | 7.2% | 4.6% | 2.6% | 1.9% | 0.6% | 0.9% | 2.7% | 5.0% |
| Net interest, other income & income taxes | 15 | −561 | 321 | 586 | 774 | 355 | −700 | −1,587 |
| GAAP net income to common | 7,091 | 3,794 | 2,378 | 2,639 | 1,547 | 1,606 | 3,228 | 6,477 |
| Non-GAAP net income (company definition) | n/d | n/d | 4,303 | 5,519 | 5,502 | 5,872 | 7,809 | 11,381 |
| Adjusted EBITDA (company definition) | 16,056 | 14,596 | 10,841 | 13,773 | 14,328 | 17,357 | 22,061 | 27,256 |
| Balance sheet (model net-asset basis from 30 Sep 2026) | ||||||||
| Cash, cash equivalents & short-term investments | 36,563 | 44,059 | 45,447 | 41,617 | 31,035 | 25,000 | 25,000 | 27,596 |
| Depreciable operating assets (excl. $2.9bn SpaceX stake) | n/d | n/d | 59,091 | 64,292 | 80,605 | 99,642 | 107,313 | 110,287 |
| of which programme assets (SI, fab, Cybercab, Optimus) | n/d | n/d | 10,956 | 15,276 | 28,128 | 43,743 | 48,138 | 47,314 |
| Debt & finance leases | 8,213 | 8,376 | 9,523 | 9,523 | 9,523 | 16,336 | 15,803 | 9,523 |
| Total stockholders’ equity | 72,913 | 82,137 | 89,289 | 90,686 | 96,949 | 103,664 | 112,399 | 124,792 |
| Net cash (cash & investments less debt) | 28,350 | 35,683 | 35,924 | 32,094 | 21,512 | 8,664 | 9,197 | 18,073 |
| Cash flow statement | ||||||||
| Net cash from operating activities (OCF) | 14,923 | 14,747 | 14,897 | 18,067 | 14,571 | 17,186 | 20,829 | 25,124 |
| Capital expenditure (core + estimated venture) | 11,342 | 8,527 | 13,014 | 20,014 | 25,153 | 30,034 | 20,297 | 16,249 |
| Free cash flow (company definition) | 3,581 | 6,220 | 1,883 | −1,947 | −10,582 | −12,848 | 533 | 8,875 |
| FCF after employee SBC* / Facility draw (repay) | n/d | n/d | n/d | −4,692 (4Q26E) / 0 | −14,201 / 0 | −16,861/+6,813 | −3,880/−533 | +4,054/−6,280 |
Source: FY2024–25 10-K, Q3 2026 10-Q, Penmark Research model. Shaded columns are Penmark estimates; *4Q26E only (not FY26E annual); n/d = not disclosed on model basis.
Quarterly path (2Q25A–4Q26E), pillar profit build & valuation multiples at $390.22 and $333.38 target
| $m, except per share, k, GWh, m | 2Q25A | 3Q25A | 4Q25A | 1Q26A | 2Q26A | 3Q26A | 4Q26E |
|---|---|---|---|---|---|---|---|
| Total revenues | 22,496 | 28,095 | 24,901 | 22,387 | 28,236 | 28,046 | 28,720 |
| Automotive (of which reg. credits) | 16,661 (439) | 21,205 (417) | 17,693 (542) | 16,234 (380) | 20,516 (146) | 20,560 (113) | 20,260 (100) |
| Energy storage / Services & other | 2,789 / 3,046 | 3,415 / 3,475 | 3,837 / 3,371 | 2,408 / 3,745 | 3,139 / 4,581 | 2,881 / 4,605 | 3,760 / 4,700 |
| Gross profit (Gross margin %) | 3,878 (17.2%) | 5,054 (18.0%) | 5,009 (20.1%) | 4,720 (21.1%) | 4,751 (16.8%) | 5,494 (19.6%) | 5,172 (18.0%) |
| R&D / SG&A | 1,589 / 1,366 | 1,630 / 1,562 | 1,783 / 1,655 | 1,946 / 1,833 | 2,371 / 1,982 | 2,761 / 2,015 | 3,092 / 2,084 |
| GAAP operating income (EBIT) | 923 | 1,624 | 1,409 | 941 | 398 | 718 | −5 |
| GAAP NI / Non-GAAP NI | 1,172 / 1,393 | 1,373 / 1,770 | 840 / 1,761 | 477 / 1,453 | 1,114 / 1,153 | 787 / 1,697 | 261 / 1,216 |
| GAAP EPS ($) / Non-GAAP EPS ($) | 0.33 / 0.40 | 0.39 / 0.50 | 0.24 / 0.50 | 0.13 / 0.41 | 0.32 / 0.33 | 0.22 / 0.48 | 0.07 / 0.34 |
| Adj. EBITDA / Free cash flow | 3,401 / 146 | 4,227 / 3,990 | 4,154 / 1,420 | 3,668 / 1,444 | 3,273 / −1,092 | 3,900 / 1,531 | 2,932 / −3,830 |
| Deliveries (k) / BESS (GWh) / FSD (m) | 384 / 9.6 / 0.95 | 497 / 12.5 / 1.04 | 418 / 14.2 / 1.10 | 358 / 8.8 / 1.28 | 480 / 13.5 / 1.48 | 487 / 13.7 / 1.74 | 480 / 16.0 / 1.95 |
Source: Q2 & Q3 2026 Form 8-K Updates, Q3 10-Q, Signals KPIs, Penmark model (4Q26E).
| Pillar & ratio detail | FY24A | FY25A | FY26E | FY27E | FY28E | FY29E | FY30E |
|---|---|---|---|---|---|---|---|
| Core pillar EBIT ($m, ex $1,095m/yr CEO award) | |||||||
| Automotive & services EBIT / Energy EBIT | n/d | n/d | n/d | 5,762 / 2,408 | 6,858 / 2,917 | 8,017 / 3,359 | 8,766 / 3,735 |
| FSD EBIT (after $3.5bn R&D) / Programme EBIT | n/d | n/d | n/d | −2,154 / −4,148 | −1,044 / −6,385 | 752 / −7,105 | 3,482 / −6,823 |
| Per-share data, returns, leverage & multiples ($390.22 price, 13 Nov 2026) | |||||||
| Diluted shares ex unearned award (m) | 3,498.0 | 3,528.0 | 3,544.0 | 3,544.0 | 3,544.0 | 3,544.0 | 3,544.0 |
| GAAP EPS ($) / Non-GAAP EPS ($) | 2.04 / n/d | 1.08 / n/d | 0.74 / 1.56 | 0.44 / 1.55 | 0.45 / 1.66 | 0.91 / 2.20 | 1.83 / 3.21 |
| ROE (GAAP NI / avg. common equity) | 10.5% | 4.9% | 3.1% | 1.6% | 1.6% | 3.0% | 5.5% |
| ROCE (NOPAT / avg. invested capital) | 12.6% | 7.5% | 3.0% | 0.9% | 1.1% | 3.1% | 6.0% |
| Net debt / Adj. EBITDA (negative = net cash) | −1.8x | −2.4x | −2.3x | −1.5x | −0.5x | −0.4x | −0.7x |
| Non-GAAP P/E (x) at $390.22 (GAAP P/E) | n/d (191.3x) | n/d (361.3x) | 249.6x (524.8x) | 251.4x (893.7x) | 235.5x (860.9x) | 177.1x (428.4x) | 121.5x (213.5x) |
| EV / Adj. EBITDA (x) at $390.22 ($1,506.5bn EV) | 93.8x | 103.2x | 109.4x | 105.1x | 86.8x | 68.3x | 55.3x |
| FCF yield (%) / Dividend yield (%) at $390.22 | 0.3% / 0.0% | 0.5% / 0.0% | −0.1% / 0.0% | −0.8% / 0.0% | −0.9% / 0.0% | 0.0% / 0.0% | 0.6% / 0.0% |
| Non-GAAP P/E (x) at our $333.38 target | n/d | n/d | 213.3x | 214.7x | 201.2x | 151.3x | 103.8x |
Source: Filings, Penmark Research model. Per-share multiples & FCF yield use diluted shares (3,544.01m FY26E+; $1,382.9bn diluted cap), while EV ($1,506.5bn) uses 3,952.76m total cover shares ($1,542.4bn cap incl. 423.74m unearned CEO award).
Reference: GAAP-to-non-GAAP reconciliation, glossary, definitions, peer set & methodology
| $m, Dec year-end | FY24A | FY25A | 9M26A | 4Q26E | FY26E | FY27E | FY28E |
|---|---|---|---|---|---|---|---|
| GAAP net income to common stockholders | 7,091 | 3,794 | 2,378 | 261 | 2,639 | 1,547 | 1,606 |
| Add: Stock-based compensation (employee + CEO award) | 1,999 | 2,825 | 3,346 | 1,137 | 4,483 | 4,715 | 5,109 |
| Less: Tax / SpaceX mark & other company non-GAAP adj. | n/d | n/d | −1,421 | −181 | −1,602 | −760 | −843 |
| Non-GAAP net income (company definition) | n/d | n/d | 4,303 | 1,216 | 5,519 | 5,502 | 5,872 |
| Memo: GAAP EBIT + D&A + SBC = Company Adj. EBITDA* | 16,056 | 14,596 | 10,841 | 2,932 | 13,773 | 14,328 | 17,357 |
Source: Q3 2026 Update, Penmark model. *FY24A–25A incl. restructuring/NCI lines; Signals standardised FY25A EBITDA ex SBC add-back is $9,385m.
Glossary of company & sector terms
- FSD (Supervised / Unsupervised): Tesla’s camera-based end-to-end neural-network driver-assistance ($99/mo in NA; 1.74m active subs in 3Q26) and target autonomous software stack.
- Cybercab: Dedicated two-seat autonomous robotaxi without steering wheel or pedals; Dallas pilot from Nov 2026.
- Megapack & GWh: Utility-scale lithium-ion BESS measured in gigawatt-hours of energy capacity (distinct from GW power rating).
- Optimus: Humanoid bi-pedal robot in pilot Fremont assembly; external sales targeted late 2027.
- Terafab & AI5/AI6: Planned high-volume semiconductor/compute and cell manufacturing facilities driving FY27E–28E venture capex.
- IEEPA refunds: 3Q26 customs duty credits of $526m in energy COGS and $260m in auto COGS less $339m owed to storage customers ($447m net company-wide; $187m net energy).
Methodology note & departures
Hybrid archetype: Primary Products & units (vehicles, BESS) + Recurring revenue (FSD carved out FY27E+) + Pipeline (4-outcome robotaxi & Optimus DCFs), valued via SOTP across one 14-year DCF engine (FQ4 26E–FY40E). Situation flags: controlled/key-person (Musk 19.8%), heavy AI capex cycle, Low conviction.
Departures & limits: Annual historical non-GAAP NI/EPS not disclosed on a comparable basis are shown as n/d; post-FY26E forecasts are annual; SpaceX merger is unvalued (paper-swap check shown). Reporting currency: US$ (domestic US issuer, no FX/ADR adjustment).
Primary data sources (cut-off 13–14 Nov 2026)
- SEC filings & Signals data: FY21–25 10-K, 3Q26 10-Q (22 Oct 26), 8-Ks, DEF 14A, calls (4Q24–3Q26), KPIs/ratios, 13F, Form 4, short interest.
- Market & industry: Yahoo Finance (13–14 Nov 26), MarketScreener (Jan–Apr 26 stale EBITDA), US Treasury (5.15% 10Y), Damodaran ERP (May 26), IEA, InfoLink/SEIA, BYD & Waymo.
| Measure | Exact definition in Penmark model | Basis / Scope |
|---|---|---|
| Implied P/E (actual & target) | Share price ($390.22) or 12m target ($333.38) ÷ Non-GAAP diluted EPS ($1.56 FY26E, $1.55 FY27E). | 3,544.0m diluted sh. |
| Enterprise value (EV) | Cover market cap ($1,542.45bn on 3,952.8m sh.) − 3Q26 cash & ST inv. ($45.45bn) + debt ($9.52bn) = $1,506.52bn. | Consolidated EV |
| ROE / ROCE / FCF yield | ROE = GAAP NI ÷ avg. common equity; ROCE = NOPAT (22% tax) ÷ avg. invested capital; FCF yield on diluted sh. | Standardised annual |
| Rating & 12m target rule | Probability-weighted value ($298.69) × (1 + 11.616% Ke) = $333.38; Buy >+10%, Hold −10% to +10%, Sell <−10%. | Price return ex div. |
| Company / mark | Role & why comparable to Tesla’s business lines | Scale / mark | Fwd P/E / mult. |
|---|---|---|---|
| GM, Ford, Stellantis | Mass-market automaker cohort setting our 6.13x CY26E forward P/E core cross-check (repriced 13 Nov 26). | $86 / $12 / $4 sh | 6.1x / 6.3x / 5.1x |
| Toyota, BYD, Rivian, Ferrari | Global EV/auto cohorts comparable on scale (Toyota/BYD), pure-play EV (Rivian) & luxury margin (Ferrari). | 2.26m BYD BEV | 9.1x–37.0x trl. |
| Waymo & Fluence Energy | Outside SOTP benchmarks: Waymo autonomous ride-hailing (~4k AVs; Feb 26 private round) & Fluence BESS (FQ3 26 10-Q). | $126bn Waymo | 1.42x EV/sales |
Source: Penmark Research model, Signals, Yahoo Finance, Fluence FQ3 26 Form 10-Q (30 Jun 2026), reported Feb 2026 Waymo round.
Analyst certification and important disclosures
Ratings
Ratings are based on the upside from the share price to our 12-month price target, excluding dividends. The price target is weighted across bull, base and bear scenarios.
| Buy | Upside to price target above +10% |
| Hold | Upside to price target from −10% to +10%, inclusive |
| Sell | Upside to price target below −10% |
We review ratings at each set of results and whenever the facts change materially. A share price can move outside its band before the rating changes, and targets may not be reached.
Analyst certification
The Penmark Team certifies that (1) the views in this report accurately reflect its views about the subject company and its securities, and (2) no part of its compensation was, is or will be directly or indirectly related to the specific ratings, price targets or views in this report.
Contact
Penmark Research
Questions about our research:
research@penmarkresearch.com
All our research and coverage:
penmarkresearch.com
Basis of preparation
This report uses information publicly available up to its publication date. Share prices are closing prices on the trading day before the publication date, unless stated otherwise. Forecasts, valuations and price targets are Penmark Research’s own, and forecast periods are marked E. Sources are shown beneath each exhibit.
Valuation and price targets
Price targets are based on the valuation methods set out in each report and are weighted across bull, base and bear scenarios. The main risks to each rating and price target are described in the report. Penmark Research updates its coverage after each set of results but is not obliged to update a report at any other time.
Independence and conflicts of interest
Penmark Research is independent. It does not provide investment banking, brokerage, market-making or asset management services, does not trade securities, and does not accept payment from any company for research coverage. Companies do not see or review Penmark Research reports before publication.
No member of the Penmark Team holds a long or short position, directly or through derivatives, in the securities of any company Penmark Research covers.
Regulatory status
Penmark Research publishes general, impersonal investment research on a regular basis. It is not registered as an investment adviser with the US Securities and Exchange Commission or any state securities authority, is not a registered broker-dealer and is not a member of FINRA. Penmark Research does not give advice tailored to any person’s circumstances.
Not investment advice or an offer
This report is for information only. It is not personalised investment advice and is not an offer or solicitation to buy or sell any security or other financial instrument. It does not take into account any reader’s objectives, financial situation or needs. Readers should make their own investment decisions and seek independent professional advice where appropriate.
Forward-looking statements and risk
Forecasts, valuations and price targets are estimates based on assumptions that may prove wrong, and they may not be achieved. Opinions are current as of the publication date and may change without notice. Investing in equities involves risk, including the loss of capital. Share prices can be volatile, and past performance is not a reliable indicator of future results.
Data and sources
Company financials, operating data and filings come from company filings, earnings releases and earnings calls. Market data and any consensus estimates come from third-party sources named beneath the relevant exhibit; consensus figures from aggregators are unofficial. Penmark Research may reference publicly available third-party research, broker estimates, consensus data and market targets for comparison, while all Penmark Research forecasts, ratings and valuations remain proprietary. Third-party data belong to their providers and may not be extracted from this report.
Accuracy and liability
Information is taken from sources believed to be reliable, but Penmark Research makes no representation or warranty as to its accuracy, completeness or timeliness. To the fullest extent permitted by law, Penmark Research accepts no liability for any loss arising from use of this report. Descriptions of litigation and regulatory matters reflect allegations and public records, not findings, unless stated. If a published report is corrected, the corrected version carries an “Updated” date at penmarkresearch.com.
Distribution and access
Penmark Research reports are available to registered users of penmarkresearch.com. Downloads and programmatic access are governed by the Penmark Research subscription terms. This report is not directed at, or intended for, any person in Singapore or India, and access from those countries is blocked. It is not intended for distribution to, or use by, any person in any jurisdiction where that would be contrary to law or regulation or would subject Penmark Research to registration or licensing requirements there.
Copyright and permitted use
© Penmark Research. All rights reserved. Penmark Research is a trade name of Brightriver Labs. Readers may share a link to this report but may not copy, reproduce, redistribute, sell or use its content, including for text and data mining, without written consent. Contact: research@penmarkresearch.com.